Skip to content
Thursday, November 12, 2026
Harbor Group

The Zimbabwean Government Declines ‘Unbalanced’ US Healthcare Assistance Deal Over Data Apprehensions

Medical funding illustration
The offered American financial assistance would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has turned down a major American health deal valued at $367m (£272m) over five years because of the United States' request for sensitive data.

This move came to light following a official document dated December was disclosed, which showed President Emmerson Mnangagwa deemed the deal was "skewed".

An official representative later stated that the United States was requesting genetic material for research and profit but was unwilling to guarantee the resulting advantages from future medical innovations.

"We will now turn to the difficult and regrettable task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had provided more than $1.9bn as health assistance to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has appealed for further negotiations to reach a agreement acceptable to all parties so the nation's critical HIV treatment initiative can continue.

Broader Implications

This rejection follows a similar situation in neighbouring Kenya, where a court suspended a related deal with the US following legal challenges were raised about the safety of Kenyans' medical information.

After resuming the presidency recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.

The agency had administered assistance for the American government, but Trump claimed its spending was "inefficient" and his government was seeking direct bilateral deals to boost transparency and responsibility.

As per reports, Sixteen African countries have so far signed these new agreements, constituting more than $18.3bn in new funding.

Specifics of the Declined Deal

The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this cooperation could have provided immense advantages for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment through US-supported initiatives," Tremont said.

However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".

"The proposal required Zimbabwe to share its biological resources and data over an extended period, without any equivalent guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," he stated.

"In essence, our country would supply the basic resources for scientific discovery without any certainty that the final treatments would be accessible to our citizens if a new health crisis emerge."

Sovereignty and International Frameworks

Mangwana further pointed out that the American exit from the global health body and its pursuit of one-on-one health agreements were disrupting frameworks previously set up via the international organization.

Mangwana cited its Pathogen Access and Benefit Sharing scheme created to manage potential pandemics.

"This mechanism is intended to ensure that when a nation provides its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to develop them."

The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," he added.

"We welcome continued dialogue with our American counterparts on how subsequent collaboration could be designed in a way that honours the sovereignty and interests of each country."

Health Experts Reaction

A leading public health body said it recognised the official position, but recommended that negotiations should continue given that a large portion of the country's Aids initiatives depended on international support.

"If technical issues exist, such as those relating to information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," it added.

This impasse highlights the ongoing challenges between accepting much-needed foreign assistance and protecting a country's data in an ever more interconnected world.

About the author

David Rivas

Maya Chen is a certified financial planner with over 15 years of experience in portfolio management and retirement planning, specializing in high-net-worth clients.

Harbor Group

Type to search articles.